Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Cell factor composition for immune regulation

An immunotherapeutic drug and a technology of body immunity, which is applied in the field of immunotherapy for tumor diseases, and can solve problems such as high cost, unsatisfactory clinical immunotherapy effect, and complicated preparation process

Inactive Publication Date: 2010-12-01
BEIJING KAWIN TECH SHARE HLDG +1
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

T cells need individualized treatment, the preparation process is complicated, the cost is high, and the effect of clinical immunotherapy is not very satisfactory

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Cell factor composition for immune regulation
  • Cell factor composition for immune regulation
  • Cell factor composition for immune regulation

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0020] The present invention is further illustrated by the following examples, but any example or combination thereof should not be construed as limiting the scope or implementation of the present invention. The scope of the present invention is defined by the appended claims, and those skilled in the art can clearly understand the scope defined by the claims in combination with the description and common knowledge in the field. Without departing from the spirit and scope of the present invention, those skilled in the art may make any modifications or changes to the technical solutions of the present invention, and such modifications and changes are also included in the scope of the present invention.

[0021] The main purpose of this study is to compare the immunotherapy effect of interleukin 15, interleukin 18, and the combined use of interleukin 15 and interleukin 18 on myeloma model mice. Activity, the level of IFN-γ in the body and the inhibitory effect on myeloma to refl...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a medicament for regulating the immunity of organisms by combining a certain amount of interleukin 15 and a certain amount of interleukin 18, which have effect on decreased immunity caused by tumors. The medicament is used for treating tumor diseases by regulating the immunity of the organisms.

Description

technical field [0001] The present invention relates to the field of immunotherapy for tumor diseases by using a combination of a certain amount of interleukin 15 and a certain amount of interleukin 18 effective for immune decline caused by tumors to regulate the immune level of the body. Background technique [0002] The immune system is one of the most important immune systems of the human body. A normal immune response enables the human body to resist infection, identify self and non-self, remove aging and degenerated cells in the body in time, monitor and eliminate mutant cells. Tumor cells are mutated cells of the human body. As long as the immune function of the human body, especially the tumor-specific immune function, is fully mobilized, tumor cells can be eliminated. [0003] The purpose of tumor immunology treatment is to stimulate or mobilize the body's immune system and enhance the immunity of the tumor microenvironment, thereby controlling and killing tumor cell...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/20A61P37/04A61P35/00
Inventor 侯建华周德胜熊国裕杨璐
Owner BEIJING KAWIN TECH SHARE HLDG
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products